Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnesium in Treating Subarachnoid Hemorrhage Related Vasospasm, A Haptoglobin Genomic Based Randomized Controlled Trial

NCT04613960 is registered in ClinicalTrials.gov with General Committee of Teaching Hospitals and Institutes, Egypt as lead sponsor.

NCT NCT04613960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04613960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnesium in Treating Subarachnoid Hemorrhage Related Vasospasm, A Haptoglobin Genomic Based Randomized Controlled Trial
Lead sponsor
General Committee of Teaching Hospitals and Institutes, Egypt
Phase
Phase 2/3
Overall status
Unknown status
Start date
December 31, 2022
Completion date
June 30, 2024
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral vasospasm, subarachnoid hemorrhage, aneurysmal